ZY

Zymergen Inc. [ZY] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ZY Stock Summary

In the News

ZY Financial details

Company Rating
-
Market Cap
0
Income
-364.95M
Revenue
14.09M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
502
Optionable
No
Shortable
Yes
Earnings
03 Nov 2022
P/E
-1.33
Forward P/E
-
PEG
-0.41
P/S
-
P/B
1.06
P/C
-
P/FCF
-
Quick Ratio
4.16
Current Ratio
4.59
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.55
EPS next Y
-
EPS next Q
-
EPS this Y
81.72%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-46.93%
EPS Q/Q
61.43%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-40%
ROE
-65%
ROC
-0.41%
Gross Margin
-218%
Oper. Margin
-2456%
Profit Margin
-2705%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.1-11.87
52W High
-
52W Low
-
RSI
-
Rel Volume
2.26
Avg Volume
1.04M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
3V64.DE
BRK-B
1YD.DE
NVD.DE
DHR-PB
Same Sector
5290.T
AQA.TO
ZY
FVI.TO
FAME
Check Those
FAI.TO
API
KSHB
601929.SS
HEN3.F
Similar Market Cap
0KSJ.L
0515.HK
ANEW
603020.SS
002571.SZ

Company Profile

Basic Materials Chemicals - Specialty
  • Volume Average 1.04M
  • Employee 502
  • CEO Mr. Joshua J. Hoffmann
  • Headquarters EmeryVille,CA,US
  • IPO Date 2021-04-22
  • Website https://www.zymergen.com

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.